Silvia Vicenzi/LinkedIn
Dec 29, 2025, 23:55
Silvia Vicenzi: From a Hormone-Centric Model to an Immune-Centric Understanding of the Disease
Silvia Vicenzi, Business Development Manager at Biocytogen, posted on LinkedIn:
“The kind of science we need more of: rigorous, human, and deeply purpose-driven. The latest Science feature on endometriosis research highlights a critical shift in the field: from a hormone-centric model to an immune-centric understanding of the disease.

Emerging data show that endometriotic lesions are shaped by:
- immune dysregulation (macrophage activation, altered NK cell function)
- chronic inflammatory signaling (IL-6, TNF-α, prostaglandins)
- aberrant tissue remodeling and angiogenesis
- immune–epithelial cross-talk driving lesion persistence
This reframes endometriosis as a complex immuno-inflammatory disorder, not just a reproductive one.
Why this matters:
- It opens the door to non-hormonal interventions that target pathways like inflammation, cytokine signaling, or immune cell recruitment.
- It supports development of diagnostic biomarkers based on immune signatures instead of invasive surgery.
- It aligns endometriosis with broader patterns seen in autoimmune-adjacent diseases.
Women’s health research is finally gaining the scientific attention it deserves — and immunology is at the center of that shift.
If you want to read the entire article here.”
Get insights from Hemostasis Today.
-
Apr 15, 2026, 04:06Brenda Pleasant: Insights from the HFA Symposium on Hemophilia Care
-
Apr 15, 2026, 03:43Lexy Halloran: Addressing Diagnostic Inequities in Women with Chronic Conditions
-
Apr 14, 2026, 17:32Denise M.: Surviving Sepsis 2026 – The Upstream Revolution
-
Apr 14, 2026, 17:23Meghanath Yenni։ What’s New in Acute Ischemic Stroke in 2026
-
Apr 14, 2026, 17:11Phil Spinella: What Dose of TXA for Children With Severe Traumatic Bleeding Should You Use?
-
Apr 14, 2026, 17:08Abdulrahman Katib: How Endovascular Stenting Is Transforming the Treatment of Severe PTS
-
Apr 14, 2026, 17:00Anna A. Avagyan: Glad to Be Part of EHA Pediatric Hematology-Oncology Course
-
Apr 14, 2026, 16:58Ney Carter Borges: NLRP3 Inhibition in Atherosclerosis – Early Clinical Signal Beyond Lipids
-
Apr 14, 2026, 16:56Saskia Middeldorp: Key Takeaways from the 2026 ACC/AHA Guideline on Acute PE